A Neanderthal OAS1 isoform Protects Against COVID-19 Susceptibility and Severity: Results from Mendelian Randomization and Case-Control Studies
View ORCID ProfileSirui Zhou, View ORCID ProfileGuillaume Butler-Laporte, View ORCID ProfileTomoko Nakanishi, David Morrison, View ORCID ProfileJonathan Afilalo, View ORCID ProfileMarc Afilalo, View ORCID ProfileLaetitia Laurent, View ORCID ProfileMaik Pietzner, View ORCID ProfileNicola Kerrison, View ORCID ProfileKaiqiong Zhao, Elsa Brunet-Ratnasingham, Danielle Henry, Nofar Kimchi, Zaman Afrasiabi, Nardin Rezk, Meriem Bouab, Louis Petitjean, Charlotte Guzman, Xiaoqing Xue, Chris Tselios, Branka Vulesevic, Olumide Adeleye, Tala Abdullah, Noor Almamlouk, Yiheng Chen, Michaël Chassé, Madeleine Durand, Michael Pollak, Clare Paterson, View ORCID ProfileHugo Zeberg, Johan Normark, View ORCID ProfileRobert Frithiof, Miklós Lipcsey, Michael Hultström, View ORCID ProfileCelia M T Greenwood, View ORCID ProfileClaudia Langenberg, Elin Thysell, View ORCID ProfileVincent Mooser, View ORCID ProfileVincenzo Forgetta, View ORCID ProfileDaniel E. Kaufmann, View ORCID ProfileJ Brent Richards
doi: https://doi.org/10.1101/2020.10.13.20212092
Sirui Zhou
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
2Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada
Guillaume Butler-Laporte
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
2Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada
Tomoko Nakanishi
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
3Department of Human Genetics, McGill University Montréal, Québec, Canada
4Kyoto-McGill International Collaborative School in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
5Research Fellow, Japan Society for the Promotion of Science
David Morrison
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Jonathan Afilalo
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Marc Afilalo
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Laetitia Laurent
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Maik Pietzner
6MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK
Nicola Kerrison
6MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK
Kaiqiong Zhao
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
2Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada
Elsa Brunet-Ratnasingham
7Division of Infectious Diseases and Research Centre of the Centre Hospitalier de l’Université de Montréal, Montréal, Canada
Danielle Henry
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Nofar Kimchi
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Zaman Afrasiabi
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Nardin Rezk
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Meriem Bouab
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Louis Petitjean
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Charlotte Guzman
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Xiaoqing Xue
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Chris Tselios
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Branka Vulesevic
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Olumide Adeleye
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Tala Abdullah
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Noor Almamlouk
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Yiheng Chen
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Michaël Chassé
7Division of Infectious Diseases and Research Centre of the Centre Hospitalier de l’Université de Montréal, Montréal, Canada
Madeleine Durand
7Division of Infectious Diseases and Research Centre of the Centre Hospitalier de l’Université de Montréal, Montréal, Canada
Michael Pollak
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Clare Paterson
8SomaLogic, Inc., Boulder, Colorado, USA
Hugo Zeberg
9Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
Johan Normark
10Molecular Infection Medicine Sweden (MIMS), Umeå University
Robert Frithiof
11Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
Miklós Lipcsey
12Hedenstierna Laboratory, CIRRUS, Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
13Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Michael Hultström
11Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
13Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Celia M T Greenwood
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
2Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada
Claudia Langenberg
6MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK
14Computational Medicine, Berlin Institute of Health, Charité University Medicine Berlin, Germany
Elin Thysell
15Department of Medical Biosciences, Umeå University
Vincent Mooser
3Department of Human Genetics, McGill University Montréal, Québec, Canada
Vincenzo Forgetta
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Daniel E. Kaufmann
7Division of Infectious Diseases and Research Centre of the Centre Hospitalier de l’Université de Montréal, Montréal, Canada
16Department of Medicine, Université de Montréal, Montréal, Canada
J Brent Richards
1Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
2Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada
3Department of Human Genetics, McGill University Montréal, Québec, Canada
17Department of Twin Research, King’s College London, London, United Kingdom
- Supplementary Data and Figures[supplements/212092_file02.pdf]
- Supplementary Tables[supplements/212092_file03.xlsx]
Posted December 24, 2020.
A Neanderthal OAS1 isoform Protects Against COVID-19 Susceptibility and Severity: Results from Mendelian Randomization and Case-Control Studies
Sirui Zhou, Guillaume Butler-Laporte, Tomoko Nakanishi, David Morrison, Jonathan Afilalo, Marc Afilalo, Laetitia Laurent, Maik Pietzner, Nicola Kerrison, Kaiqiong Zhao, Elsa Brunet-Ratnasingham, Danielle Henry, Nofar Kimchi, Zaman Afrasiabi, Nardin Rezk, Meriem Bouab, Louis Petitjean, Charlotte Guzman, Xiaoqing Xue, Chris Tselios, Branka Vulesevic, Olumide Adeleye, Tala Abdullah, Noor Almamlouk, Yiheng Chen, Michaël Chassé, Madeleine Durand, Michael Pollak, Clare Paterson, Hugo Zeberg, Johan Normark, Robert Frithiof, Miklós Lipcsey, Michael Hultström, Celia M T Greenwood, Claudia Langenberg, Elin Thysell, Vincent Mooser, Vincenzo Forgetta, Daniel E. Kaufmann, J Brent Richards
medRxiv 2020.10.13.20212092; doi: https://doi.org/10.1101/2020.10.13.20212092
A Neanderthal OAS1 isoform Protects Against COVID-19 Susceptibility and Severity: Results from Mendelian Randomization and Case-Control Studies
Sirui Zhou, Guillaume Butler-Laporte, Tomoko Nakanishi, David Morrison, Jonathan Afilalo, Marc Afilalo, Laetitia Laurent, Maik Pietzner, Nicola Kerrison, Kaiqiong Zhao, Elsa Brunet-Ratnasingham, Danielle Henry, Nofar Kimchi, Zaman Afrasiabi, Nardin Rezk, Meriem Bouab, Louis Petitjean, Charlotte Guzman, Xiaoqing Xue, Chris Tselios, Branka Vulesevic, Olumide Adeleye, Tala Abdullah, Noor Almamlouk, Yiheng Chen, Michaël Chassé, Madeleine Durand, Michael Pollak, Clare Paterson, Hugo Zeberg, Johan Normark, Robert Frithiof, Miklós Lipcsey, Michael Hultström, Celia M T Greenwood, Claudia Langenberg, Elin Thysell, Vincent Mooser, Vincenzo Forgetta, Daniel E. Kaufmann, J Brent Richards
medRxiv 2020.10.13.20212092; doi: https://doi.org/10.1101/2020.10.13.20212092
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2931)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12734)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4578)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (424)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4345)
- Nursing (236)
- Nutrition (638)
- Oncology (2266)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1526)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)